C4A and infection: Recently, it was demonstrated that vaccine-linked chemotherapy using a bivalent vaccine containing both the Tc24-C4 and TSA1-C4 recombinant protein antigens combined with E6020 SE adjuvant significantly reduced cardiac fibrosis in a chronic model of infection (Dzul-Huchim et al., 2022).